论文部分内容阅读
1987年9月26日,上海市医药公司和意大利法米塔里亚·卡罗埃尔巴公司联合召开表阿霉素、格列吡嗪临床应用推广会。出席会议的由临床医师、药师及有关人员180多人。会上,分别有胡远峰、孙曾一教授重点介绍格列吡嗪和表阿霉素的临床应用情况。格列吡嗪(glipizide,商品名美吡达)是第二代磺脲化合物中较安全有效的药物。上海第一、第四人民医院胡远峰等,使用意大利法米塔里亚·卡罗埃尔巴公司生产的格列吡嗪,治疗62例非胰岛素依赖型糖尿病患者(详细临床资料见《新药与临床》1987年第6卷第4期193-197页——编者注):在新近诊断未经治疗的41例中,有效35例(85％),21例各种
September 26, 1987, the Shanghai Pharmaceutical Company and the Italian Faridaria Carlo Erba joint holding of epirubicin, glipizide clinical application promotion. Attend the meeting by the clinicians, pharmacists and related personnel more than 180 people. At the meeting, Professor Hu Yuanfeng and Professor Sun Zengyi respectively introduced the clinical application of glipizide and epirubicin. Glipizide (trade name pyridostigmine) is the second generation of sulfonylurea compounds safer and more effective drugs. Shanghai First People’s Hospital of the Fourth People’s Hospital Hu Yuanfeng, etc., the use of Italy Fabitalia Carlo Erba produced glipizide treatment of 62 patients with non-insulin-dependent diabetes (detailed clinical information, see "New Drugs and Clinical Volume 6, No. 4, 1987, pp. 193-197 - Editor’s Note: Of the 41 newly diagnosed untreated cases, 35 (85%) were effective and 21